Labiotech.eu

News and Trends 12 Mar 2020

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

An antibiotic-free vaginal tablet developed by the Swedish company Gedea Biotech has cured 82% of women of the common vaginal infection bacterial vaginosis in a 24-patient clinical trial. Bacterial vaginosis occurs when the normal vaginal microflora — characterized by a high proportion of bacteria from the genus Lactobacillus — become unbalanced with an overgrowth of […]

March 12, 2020 - 3 minutesmins - By Laura Cowen

Expert Advice 12 Mar 2020

Five Challenges For Life Science Marketers in 2020

Developing a new drug has an estimated cost of €583M to €2.4B. Much of this spending goes towards companies, such as vendors, CROs, and CDMOs, who generate value by commercializing and industrializing innovations to improve the ways researchers study organisms and viruses in the early stages of drug development. For those of us in sales […]

March 12, 2020 - 14 minutesmins - By Mark Livingstone

Expert Advice 11 Mar 2020

Why Women’s Health Can Be a Good Investment

Since the Hormone Replacement Therapy market was destroyed almost overnight in 2002 after side effects were reported by researchers, there has been a lot of caution about investing in companies with a focus on women’s health. Mary Kerr, CEO of KaNDy Therapeutics and NeRRe Therapeutics, knows this only too well, but has not let it […]

March 11, 2020 - 13 minutesmins - By Helen Albert

multiple sclerosis neuron sheath medday Pharma

News and Trends 11 Mar 2020

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms of multiple sclerosis in a phase III trial. The 642 patients recruited into the trial received either a placebo or a high dose of pharmaceutical-grade Biotin, also known as vitamin B₇. The patients had various forms of the autoimmune condition […]

March 11, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 11 Mar 2020

Update: Carmat’s Artificial Heart Reaches Two Year Milestone

Update (11/03/2020): In a record first, Carmat announced today that one patient in its artificial heart trial has had the device implanted for 2 years. “Passing a two-year period of individual functioning is very encouraging, and confirms the capacity of our device to provide long-term support, which is one of our two key objectives along […]

March 11, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 10 Mar 2020

LSP Raises €528M in Largest European Life Sciences Investment Fund

Healthcare investor Life Sciences Partners has closed the largest ever European venture capital fund dedicated to new medicines and technologies after raising €528M. LSP 6, the company’s largest private equity fund to date, attracted significantly more than the original €396M target from a diverse investor group that included governments and the EU-supported European Investment Fund. […]

March 10, 2020 - 2 minutesmins - By External Contributor

Startup Scout 6 Mar 2020

This Startup Is Developing a DIY Biomarker Diagnostics Kit

The Swedish medical device startup Qlife is developing a diagnostic kit that patients can use at home to better control chronic diseases. Mission: To make convenient diagnostics for patients with a home-use kit that they can use to monitor blood biomarkers in chronic conditions such as arthritis. Chronic disorders such as cardiovascular disease and diabetes […]

March 6, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 5 Mar 2020

Drug Development Costs Lower Than Pharma Companies Claim

A team of UK and Belgian scientists has reported that drug companies spend up to €1.3B less on drug development than previously suggested, which raises questions about high drug prices set by some biotech and pharma companies. The study, published in the journal JAMA, took publicly available data from pharma company financial reports with the […]

March 5, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 4 Mar 2020

Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B

UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding round for the company, which specializes in redirecting and activating T-cells, includes an international group of new investors led by the US private equity firm […]

March 4, 2020 - 2 minutesmins - By External Contributor

News and Trends 4 Mar 2020

CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout

UK cell culture specialist CN Bio Innovations has secured €7.98M (£7M) from Chinese investors to bolster its US market and expand European activities. Investment in the bioengineering company was led by Chinese investor CITIC Securities Company and with further support from existing Hong Kong-based investor CN Innovations Holdings. CN Bio, which creates benchtop instruments to […]

March 4, 2020 - 3 minutesmins - By External Contributor

News and Trends 3 Mar 2020

Alnylam Gets Second RNAi Drug Approval from EMA

US biotech Alnylam Pharmaceuticals has succeeded in getting its second RNAi drug — for treatment of rare, inherited liver diseases — approved by the European Medicines Authority just months after achieving US FDA approval for the same drug. Alnylam are well known for being pioneers in the RNA interference space. The company achieved the first […]

March 3, 2020 - 2 minutesmins - By Helen Albert

In Depth 3 Mar 2020

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them at risk of long-term complications. Immunotherapy could one day become an insulin-free alternative to stop, prevent, and potentially cure this chronic disease. Type 1 diabetes is an autoimmune disease where the insulin-producing beta cells in […]

March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

Five Challenges For Life Science Marketers in 2020

Why Women’s Health Can Be a Good Investment

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

Update: Carmat’s Artificial Heart Reaches Two Year Milestone

LSP Raises €528M in Largest European Life Sciences Investment Fund

This Startup Is Developing a DIY Biomarker Diagnostics Kit

Drug Development Costs Lower Than Pharma Companies Claim

Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B

CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout

Alnylam Gets Second RNAi Drug Approval from EMA

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!